Tirzepatide TR5 5mg

Tirzepatide 5mg Injection (Mounjaro) is a once-weekly treatment for type 2 diabetes. It works by activating both GIP and GLP-1 receptors to improve blood sugar control, reduce appetite, and support weight management.

Description

Tirzepatide 5mg (Mounjaro

Tirzepatide TR5 5mg

Tirzepatide TR5 5mg โ€“ 5mg ร— 10 Vials

Cagrilintide CAG5 is a premium research peptide formulated for metabolic and appetite regulation studies. Each kit contains 10 sterile lyophilized vials with 5mg potency, manufactured to ensure high purity, stability, and consistency for laboratory research applications.

Cagrilintide is a long-acting amylin analog widely researched for its potential role in appetite control, gastric emptying, energy balance, and body weight management. The CAG5 formulation is suitable for a variety of metabolic and peptide research protocols requiring reliable low-dose concentration.

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide TR5 5mg”

Your email address will not be published. Required fields are marked *